There's no doubt that money can be made by owning shares of unprofitable businesses. For example, biotech and mining...

Vivoryon Therapeutics NV (WBO:VVYN) showcases promising developments in kidney disease treatment while navigating reduced R&D spending and financial constraints.

Vivoryon Therapeutics NV (WBO:VVYN) reports significant reduction in net loss and promising clinical data, while navigating cash flow challenges and leadership changes.

The European stock market has recently experienced a boost, with the pan-European STOXX Europe 600 Index reaching record levels amid a rally in technology stocks and expectations for lower U.S. borrowing costs. This positive momentum creates an intriguing backdrop for investors exploring opportunities in smaller or newer companies, often referred to as penny stocks. Although the term 'penny stock' might seem outdated, these investments can still offer significant growth potential when backed...

Vivoryon Therapeutics NV (FRA:05Y) reports significant R&D cost reductions and patent achievements, while navigating liquidity constraints and exploring new partnerships.